1241 ET - Hims & Hers Health's Zava acquisition will expand the company's footprint to major European countries with categories that overlap nicely with its existing offerings, BofA Securities analysts said in a note. However, expanding internationally is a risky move as Hims' core U.S. growth slows. The strategy could reflect product saturation and rising competition domestically. U.S. healthcare technology companies, like Oracle's Cerner and Teladoc's BetterHelp, have had little success in such markets given different regulatory environments in each country. Questions around Hims' future growth prospects remain, the analysts said.(kelly.cloonan@wsj.com)
(END) Dow Jones Newswires
June 03, 2025 12:41 ET (16:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。